• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化糖尿病肾病患者肾病转诊的时机。

Optimizing the timing of nephrology referral for patients with diabetic kidney disease.

作者信息

Martínez-Castelao Alberto, Soler María José, Górriz Teruel José Luis, Navarro-González Juan F, Fernandez-Fernandez Beatriz, de Alvaro Moreno Fernando, Ortiz Alberto

机构信息

Nephrology department, Bellvitge University Hospital, Barcelona, Spain.

GEENDIAB (Grupo Español de Estudio de la Nefropatía Diabética), Sociedad Española Nefrología (SEN), Santander, Spain.

出版信息

Clin Kidney J. 2020 Aug 5;14(1):5-8. doi: 10.1093/ckj/sfaa125. eCollection 2021 Jan.

DOI:10.1093/ckj/sfaa125
PMID:33564400
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7857795/
Abstract

Age-standardized rates of diabetes mellitus (DM)-related complications, such as acute myocardial infarction, stroke or amputations, have decreased in recent years, but this was not associated with a clear reduction of the incidence of advanced chronic kidney disease (CKD) requiring renal replacement therapy. The early detection of diabetic kidney disease (DKD) is a key to reduce complications, morbidity and mortality. Consensus documents and clinical practice guidelines recommend referral of DM patients to nephrology when the estimated glomerular filtration rate falls below 30 mL/min/1.73 m or when albuminuria exceeds 300 mg/g urinary creatinine. Conceptually, it strikes as odd that patients with CKD are referred to the specialist caring for the prevention and treatment of CKD only when >70% of the functioning kidney mass has been lost. The increasing global health burden of CKD, driven in large part by DKD, the suboptimal impact of routine care on DKD outcomes as compared with other DM complications, the realization that successful therapy of CKD requires early diagnosis and intervention, the advances in earlier diagnosis of kidney injury and the recent availability of antidiabetic drugs with a renal mechanism of action and lack of hypoglycaemia risk, which additionally are cardio- and nephroprotective, all point towards a paradigm shift in the care for DM patients in which they should be referred earlier to nephrology as part of a coordinated and integrated care approach.

摘要

近年来,糖尿病(DM)相关并发症(如急性心肌梗死、中风或截肢)的年龄标准化发病率有所下降,但这与需要肾脏替代治疗的晚期慢性肾脏病(CKD)发病率的明显降低并无关联。糖尿病肾病(DKD)的早期检测是降低并发症、发病率和死亡率的关键。共识文件和临床实践指南建议,当估计肾小球滤过率低于30 mL/min/1.73 m²或尿白蛋白排泄率超过300 mg/g尿肌酐时,将糖尿病患者转诊至肾脏病科。从概念上讲,当CKD患者功能性肾组织丢失超过70%时才被转诊至负责CKD防治的专科医生处,这显得有些奇怪。全球CKD健康负担不断增加,很大程度上是由DKD所致;与其他糖尿病并发症相比,常规治疗对DKD结局的影响欠佳;认识到CKD的成功治疗需要早期诊断和干预;肾脏损伤早期诊断方面的进展;以及最近出现的具有肾脏作用机制且无低血糖风险、同时具有心脏和肾脏保护作用的抗糖尿病药物,所有这些都表明糖尿病患者的护理模式需要转变,应作为协调和综合护理方法的一部分,更早地将他们转诊至肾脏病科。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e0/7857795/21beba0bbec1/sfaa125f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e0/7857795/21beba0bbec1/sfaa125f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e0/7857795/21beba0bbec1/sfaa125f1.jpg

相似文献

1
Optimizing the timing of nephrology referral for patients with diabetic kidney disease.优化糖尿病肾病患者肾病转诊的时机。
Clin Kidney J. 2020 Aug 5;14(1):5-8. doi: 10.1093/ckj/sfaa125. eCollection 2021 Jan.
2
Kidney Disease in Diabetes糖尿病肾病
3
[Advanced chronic kidney disease].[晚期慢性肾脏病]
Nefrologia. 2008;28 Suppl 3:3-6.
4
Long-term outcomes of patients with type 2 diabetes attending a multidisciplinary diabetes kidney disease clinic.2 型糖尿病患者在多学科糖尿病肾病诊所的长期预后。
J Diabetes. 2018 Jul;10(7):572-580. doi: 10.1111/1753-0407.12626. Epub 2017 Dec 28.
5
Diabetic kidney disease in patients newly diagnosed with type-2 diabetes mellitus: Incidence and associations.新诊断2型糖尿病患者的糖尿病肾病:发病率及相关因素
Saudi J Kidney Dis Transpl. 2020 Jan-Feb;31(1):191-199. doi: 10.4103/1319-2442.279940.
6
Influence of Referral to a Combined Diabetology and Nephrology Clinic on Renal Functional Trends and Metabolic Parameters in Adults With Diabetic Kidney Disease.转诊至糖尿病与肾脏病联合门诊对成年糖尿病肾病患者肾功能趋势和代谢参数的影响。
Mayo Clin Proc Innov Qual Outcomes. 2017 Sep 1;1(2):150-160. doi: 10.1016/j.mayocpiqo.2017.07.003. eCollection 2017 Sep.
7
Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.肾病科转诊前后肾功能的下降及其对中重度慢性肾脏病患者生存的影响。
Nephrol Dial Transplant. 2006 Aug;21(8):2133-43. doi: 10.1093/ndt/gfl198. Epub 2006 Apr 27.
8
Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease.慢性肾脏病肾内科转诊的基于风险与肾小球滤过率阈值标准
Clin Kidney J. 2022 Apr 20;15(11):1996-2005. doi: 10.1093/ckj/sfac104. eCollection 2022 Nov.
9
Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.转诊至肾脏病科的进展缓慢的老年慢性肾脏病患者肾替代治疗发生率较低:一项观察性研究。
BMC Nephrol. 2017 Feb 10;18(1):59. doi: 10.1186/s12882-017-0473-1.
10
The kidney and cardiovascular outcome trials.肾脏和心血管结局试验。
J Diabetes. 2018 Feb;10(2):88-89. doi: 10.1111/1753-0407.12616.

引用本文的文献

1
PCSK9 Inhibitors: A Potential Priority Choice for Lipid Management in Patients with Diabetic Kidney Disease.前蛋白转化酶枯草溶菌素9(PCSK9)抑制剂:糖尿病肾病患者脂质管理的潜在优先选择
Drugs. 2025 Aug 14. doi: 10.1007/s40265-025-02221-w.
2
Epidemiology and referral patterns of patients living with chronic kidney disease in Johannesburg, South Africa: A single centre experience.南非约翰内斯堡慢性肾脏病患者的流行病学及转诊模式:单中心经验
PLOS Glob Public Health. 2024 Apr 18;4(4):e0003119. doi: 10.1371/journal.pgph.0003119. eCollection 2024.
3
Multicentre external validation of the prognostic model kidney failure risk equation in patients with CKD stages 3 and 4 in Peru: a retrospective cohort study.

本文引用的文献

1
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.达格列净对伴或不伴糖尿病的心力衰竭患者心力衰竭恶化和心血管死亡的影响。
JAMA. 2020 Apr 14;323(14):1353-1368. doi: 10.1001/jama.2020.1906.
2
Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study.慢性肾脏病患者的用药模式及多重用药负担:德国慢性肾脏病研究
Clin Kidney J. 2019 May 24;12(5):663-672. doi: 10.1093/ckj/sfz046. eCollection 2019 Oct.
3
The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary.
秘鲁慢性肾脏病 3 期和 4 期患者中预测模型肾衰竭风险方程的多中心外部验证:回顾性队列研究。
BMJ Open. 2024 Jan 6;14(1):e076217. doi: 10.1136/bmjopen-2023-076217.
4
Diabetes Mellitus and Diabetic Kidney Disease: The Future Is Already Here.糖尿病与糖尿病肾病:未来已来。
J Clin Med. 2023 Apr 17;12(8):2914. doi: 10.3390/jcm12082914.
5
Machine Learning Models to Predict the Risk of Rapidly Progressive Kidney Disease and the Need for Nephrology Referral in Adult Patients with Type 2 Diabetes.机器学习模型预测 2 型糖尿病成人患者快速进展性肾病风险和肾脏病转诊需求。
Int J Environ Res Public Health. 2023 Feb 15;20(4):3396. doi: 10.3390/ijerph20043396.
6
Referral patterns, disease progression and impact of the kidney failure risk equation (KFRE) in a Queensland Chronic Kidney Disease Registry (CKD.QLD) cohort: a study protocol.昆士兰慢性肾脏病登记处(CKD.QLD)队列中转诊模式、疾病进展及肾衰竭风险方程(KFRE)的影响:研究方案。
BMJ Open. 2022 Feb 22;12(2):e052790. doi: 10.1136/bmjopen-2021-052790.
7
Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia.糖尿病患者的肾脏疾病:从病理生理学到药理学方面,重点关注治疗惰性。
Int J Mol Sci. 2021 May 1;22(9):4824. doi: 10.3390/ijms22094824.
欧洲肾脏协会 - 欧洲透析与移植协会(ERA-EDTA)2016年注册报告摘要
Clin Kidney J. 2019 Feb 26;12(5):702-720. doi: 10.1093/ckj/sfz011. eCollection 2019 Oct.
4
Sodium-glucose cotransporter 2 inhibitors for diabetic kidney disease: a primer for deprescribing.用于糖尿病肾病的钠-葡萄糖协同转运蛋白2抑制剂:减药指南
Clin Kidney J. 2019 Aug 14;12(5):620-628. doi: 10.1093/ckj/sfz100. eCollection 2019 Oct.
5
Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?卡格列净与已确诊肾病的糖尿病患者肾脏事件:糖尿病肾病阿曲生坦临床评估与研究 :关于卡格列净和阿曲生坦治疗糖尿病肾病有哪些了解?
Clin Kidney J. 2019 May 31;12(3):313-321. doi: 10.1093/ckj/sfz070. eCollection 2019 Jun.
6
Sodium-glucose cotransporter inhibitors: beyond glycaemic control.钠-葡萄糖协同转运蛋白抑制剂:超越血糖控制
Clin Kidney J. 2019 Mar 6;12(3):322-325. doi: 10.1093/ckj/sfz019. eCollection 2019 Jun.
7
Effect of sodium-glucose cotransporter 2 inhibitor on proximal tubular function and injury in patients with type 2 diabetes: a randomized controlled trial.钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病患者近端肾小管功能及损伤的影响:一项随机对照试验
Clin Kidney J. 2019 Jan 4;12(3):326-332. doi: 10.1093/ckj/sfy122. eCollection 2019 Jun.
8
Clarifying the concept of chronic kidney disease for non-nephrologists.向非肾脏病专家阐明慢性肾脏病的概念。
Clin Kidney J. 2019 Feb 14;12(2):258-261. doi: 10.1093/ckj/sfz007. eCollection 2019 Apr.
9
11. Microvascular Complications and Foot Care: .11. 微血管并发症与足部护理: 。
Diabetes Care. 2019 Jan;42(Suppl 1):S124-S138. doi: 10.2337/dc19-S011.
10
Renal function at the time of nephrology referral but not dialysis initiation as a risk for death in patients with diabetes mellitus.糖尿病患者肾内科转诊时而非开始透析时的肾功能作为死亡风险因素
Clin Kidney J. 2018 Dec;11(6):762-768. doi: 10.1093/ckj/sfy032. Epub 2018 Jun 2.